Peter de Keizer

Associate Professor

Strategic program(s):

Contact

pkeizer@umcutrecht.nl

Pure profile

Recent publications

All publications

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI Benjamin Bourgeois, Emil Spreitzer, Daniel Platero-Rochart, Margret Paar, Qishun Zhou, Sinem Usluer, Peter L J de Keizer, Boudewijn M T Burgering, Pedro A Sánchez-Murcia, Tobias Madl
Nature Communications, 2025, vol. 16

A Novel Cognitive Frailty Index for Geriatric Mice Serena Marcozzi, Giorgia Bigossi, Maria Elisa Giuliani, Giovanni Lai, Beatrice Bartozzi, Marta Balietti, Tiziana Casoli, Fiorenza Orlando, Andrea Amoroso, Robertina Giacconi, Maurizio Cardelli, Francesco Piacenza, Fabrizia Lattanzio, Fabiola Olivieri, Peter L J de Keizer, Fabrizio d'Adda di Fagagna, Marco Malavolta
Aging Cell, 2025, vol. 24

Development of Reliable and High-Throughput Human Biomimetic Cartilage and Bone Models to Explore Senescence and Personalized Osteoarthritis Treatment Options Ilja Boone, Evelyn Houtman, Margo Tuerlings, Jim J. van den Berg, Johannes Lehmann, Peter L.J. de Keizer, Rob G.H.H. Nelissen, Ingrid Meulenbelt
Journal of Orthopaedic Research, 2025, vol. 43

Are immunosenescent T cells really senescent? Helena Slaets, Naomi Veeningen, Peter L.J. de Keizer, Niels Hellings, Sven Hendrix
Aging Cell, 2024, vol. 23

Identified senescence endotypes in aged cartilage are reflected in the blood metabolome Ilja Boone, Margo Tuerlings, Rodrigo Coutinho de Almeida, Johannes Lehmann, Yolande Ramos, Rob Nelissen, Eline Slagboom, Peter de Keizer, Ingrid Meulenbelt
GeroScience, 2024, vol. 46, p.2359-2369

Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis Rebeca Uceda-Castro, Andreia S. Margarido, Lesley Cornet, Serena Vegna, Kerstin Hahn, Ji Ying Song, Diana A. Putavet, Mariska van Geldorp, Ceren H. Çitirikkaya, Peter L.J. de Keizer, Leon C. ter Beek, Gerben R. Borst, Leila Akkari, Olaf van Tellingen, Marike L.D. Broekman, Claire Vennin, Jacco van Rheenen
Cell Reports Medicine, 2022, vol. 3, p.1-28

External positions

Managing Director, Founder - Statutair directeur (enkel bevoegd) + bedenken en coordineren onderzoek en ontwikkelingswerk - Cleara Biotech B.V. (indirect vanuit holding)